Invest now
Pfizer Balance Sheet Annual
BSE: 500680 | NSE: PFIZER | ISIN: INE182A01018 | Sector: Major Drugs4,600.00 -46.40 (-1.00%)Updated : 04 Sep 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 4,921.88 | 4,911.11 | 4,228.78 | 4,000.73 |
| Cash Equivalents | 3,110.76 | 493.12 | 107.66 | 28.70 |
| Other Liabilities Total | 55.42 | 56.57 | 32.33 | 42.76 |
| Common Stock Total | 45.75 | 45.75 | 45.75 | 45.75 |
| Other Current Assets Total | 35.03 | 13.49 | 14.28 | 22.30 |
| Total Assets | 4,921.88 | 4,911.11 | 4,228.78 | 4,000.73 |
| Current Portof LT Debt/ Capital Leases | 31.65 | 38.28 | 37.69 | 38.65 |
| Total Equity | 4,202.90 | 4,217.41 | 3,595.54 | 3,207.30 |
| Long Term Investments | 15.19 | 13.93 | 14.28 | 13.02 |
| Retained Earnings( Accumulated Deficit) | 4,157.15 | 2,838.92 | 2,217.79 | 1,835.00 |
| Total Common Shares Outstanding | 4.57 | 4.57 | 4.57 | 4.57 |
| Tangible Book Valueper Share Common Eq | 800.27 | 801.27 | 663.15 | 576.11 |
| Goodwill Net | 527.49 | 527.49 | 527.49 | 527.49 |
| Total Liabilities | 718.98 | 693.70 | 633.24 | 793.43 |
| Total Debt | 70.23 | 108.40 | 94.54 | 134.47 |
| Short Term Investments | 2.97 | 2,290.40 | 1,917.46 | 1,805.92 |
| Cashand Short Term Investments | 3,113.73 | 2,788.45 | 2,034.05 | 1,846.42 |
| Total Receivables Net | 181.80 | 214.70 | 239.85 | 192.95 |
| Notes Payable/ Short Term Debt | 2.50 | 2.50 | 2.50 | 2.50 |
| Accounts Receivable- Trade Net | 181.80 | 193.09 | 187.61 | 151.73 |
| Property/ Plant/ Equipment Total- Net | 156.13 | 179.46 | 151.35 | 185.46 |
| Total Current Liabilities | 627.48 | 569.51 | 546.56 | 657.35 |
| Total Inventory | 472.66 | 487.29 | 441.62 | 424.63 |
| Accounts Payable | 215.94 | 151.60 | 166.23 | 217.06 |
| Other Currentliabilities Total | 377.39 | 352.62 | 320.57 | 353.97 |
| Total Long Term Debt | 36.08 | 67.62 | 54.35 | 93.32 |
| Intangibles Net | 14.35 | 24.31 | 34.27 | 44.23 |
| Other Long Term Assets Total | 239.17 | 75.53 | 137.86 | 174.12 |
| Note Receivable- Long Term | 166.33 | 577.54 | 625.72 | 563.07 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 3,803.22 | 3,512.85 | 2,737.81 | 2,493.34 |
| Capital Lease Obligations | 36.08 | 67.62 | 54.35 | 93.32 |
| Accumulated Depreciation Total | - | -301.44 | -259.56 | -229.65 |
| Accrued Expenses | - | 24.51 | 19.57 | 45.17 |
| Other Equity Total | - | 12.07 | 11.33 | 5.88 |
| Prepaid Expenses | - | 8.92 | 8.01 | 7.04 |
| Additional Paid- In Capital | - | 1,320.67 | 1,320.67 | 1,320.67 |
| Cash | - | 4.93 | 8.93 | 11.80 |
| Property/ Plant/ Equipment Total- Gross | - | 473.26 | 410.51 | 407.18 |
*All figures in crores except per share values
Pfizer Quick Links
Pfizer Dividend Pfizer Bonus Pfizer News Pfizer AGM Pfizer Rights Pfizer Splits Pfizer Board Meetings Pfizer Key Metrics Pfizer Shareholdings Pfizer Profit Loss Pfizer Cashflow Pfizer Q1 Results Pfizer Q2 Results Pfizer Q3 Results Pfizer Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,266.15+11.15(0.89%)
1,686.60+13.70(0.82%)
2,540.00+13.30(0.53%)
4,960.00-110.00 (-2.17%)
2,807.35-55.15 (-1.93%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.